Romiplostim: an alternative treatment option besides rituximab for the management of steroid refractory idiopathic thrombocytopenic purpura.
Kapoor
Shailendra
S
D000911:Antibodies, Monoclonal / Q000008:administration & dosage*; D058846:Antibodies, Monoclonal, Murine-Derived; D019468:Disease Management; D006801:Humans; D016553:Purpura, Thrombocytopenic, Idiopathic / Q000139:chemically induced / Q000188:drug therapy*; D011961:Receptors, Fc / Q000008:administration & dosage*; D011993:Recombinant Fusion Proteins / Q000008:administration & dosage*; D000069283:Rituximab; D013256:Steroids / Q000009:adverse effects*; D013926:Thrombopoietin / Q000008:administration & dosage*; D016896:Treatment Outcome
D000911:Antibodies, Monoclonal; D058846:Antibodies, Monoclonal, Murine-Derived; D011961:Receptors, Fc; D011993:Recombinant Fusion Proteins; D013256:Steroids; D000069283:Rituximab; D013926:Thrombopoietin; C488777:romiplostim